Regional reporting of adverse drug reactions:: A new computer-based network

被引:0
|
作者
Swoboda, WJ [1 ]
Göttler, M
Hasford, J
机构
[1] Univ Munich, Dept Neurol, D-80539 Munich, Germany
[2] Univ Munich, Dept Med Informat Biometry & Epidemiol, Pharmacoepidemiol Res Grp, Munich, Germany
关键词
adverse drug reaction (ADR); adverse event (AE); reporting; network; EUROSCAPE; EDIFACT; ICH; data security; digital signature;
D O I
10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of drugs is always accompanied by the risk of adverse drug reactions (ADRs) and adverse events (AE). Generally physicians, pharmaceutical manufacturers, and pharmacists use a paper-based form for sending spontaneous ADR and AE reports to the national drug regulatory authority. Besides under-reporting, reporting lag-time and errors through data transformation are a major issue. In order to improve the current reporting situation we have set up a new computer-based, network-driven system for storing, transferring, and evaluating ADR reports. The system consists of three regional centres, one coordinating centre, and the central ADR database of the national drug regulatory authority. In the regional centres, clinical pharmacologists collect ADR data in local databases. There is a comfortable user-interface with an online help-function available. New reports are sent automatically to the Federal Agency using EUROSCAPE as a standardized electronic report form of the EU. The coordinating centre in Munich is responsible for overall performance and quality assurance. This model for a clinical health information network is of a high level of data security, is reliable and easily expandable through the use of standard tools, is fast and also inexpensive by using standard shareware products. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:S47 / S53
页数:7
相关论文
共 50 条
  • [41] Adverse drug reactions' reporting in a Mexican hospital
    Aidee Valdez-Ramirez, Lourdes
    Serrano-Medina, Aracely
    Manuel Cornejo-Bravo, Jose
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2020, 28 (06) : 660 - 662
  • [42] Recognition, reporting and evaluation of adverse drug reactions
    Thurmann, PA
    Schmitt, K
    MEDIZINISCHE KLINIK, 1998, 93 (11) : 687 - 692
  • [43] Reporting adverse drug reactions in HIV infection
    Arlett, PR
    Lee, EH
    Hooker, M
    Darbyshire, JH
    Breckenridge, AM
    GENITOURINARY MEDICINE, 1997, 73 (05): : 335 - 335
  • [44] BETTER REPORTING OF ADVERSE DRUG-REACTIONS
    JONES, G
    MANN, RD
    BRITISH MEDICAL JOURNAL, 1987, 294 (6576): : 901 - 902
  • [45] IMPROVED REPORTING OF ADVERSE DRUG-REACTIONS
    KIMELBLATT, BJ
    YOUNG, SH
    HEYWOOD, PM
    MANDALA, AR
    GENDELMAN, S
    MEHL, B
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (05): : 1086 - 1089
  • [46] SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS
    RAWLINS, MD
    QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (230): : 531 - 534
  • [47] STANDARDS FOR REPORTING ADVERSE DRUG-REACTIONS
    KIMBEL, KH
    BRITISH MEDICAL JOURNAL, 1984, 288 (6412): : 240 - 240
  • [48] Recognizing, reporting, and reducing adverse drug reactions
    Brown, SD
    Landry, FJ
    SOUTHERN MEDICAL JOURNAL, 2001, 94 (04) : 370 - 373
  • [49] ANESTHETISTS AND THE REPORTING OF ADVERSE DRUG-REACTIONS
    不详
    BRITISH MEDICAL JOURNAL, 1986, 292 (6525): : 949 - 949
  • [50] Knowledge assessment in adverse drug reactions and reporting
    Palanisamy, Sivanandy
    Kumaran, Kottur S. G. Arul
    Rajasekaran, Aiyalu
    ARCHIVES OF PHARMACY PRACTICE, 2013, 4 (03) : 104 - 119